Advertisement

Medical Treatment and its Implications on Costs. An Analysis with Process Data from the German Statutory Health Insurance

  • B. Häussler
  • K. Jacobs

Abstract

While controlling and limiting costs in the health sector has become an increasingly important issue in many industrialized countries, detailed knowledge of both the extent and the distribution of health costs (such as costs per person, or costs per case of illness, or total costs of a particular disease within a certain period of time) is very often not available. Given the limited economic resources, however, there is no doubt that economic aspects are becoming more and more important in the evaluation of medical treatment. In 1986, the total health expenditures in the Federal Republic of Germany (including those on prevention, health care, labor accidents, and disability to work) reached the mark of 200 billion DM, i.e. more than 10% of the GNP. About 60% of this total being financed by the statutory health insurance system.

Keywords

Direct Cost Statutory Health Insurance Total Health Expenditure National Ambulatory Medical Care Survey Milbank Memorial Fund 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Cohodes DR (1982) Problems in measuring the cost of illness. In: Evaluations of the health professions, vol. 5, no. 4: 381–392Google Scholar
  2. (2).
    Haussier B, Schräder WF (1984) Kontextanalyse von Behandlungsverläufen auf der Basis von Prozeßdaten der Gesetzlichen Krankenversicherung. In: Borgers D, Schräder WF (eds): Behand- lungsverläufe in der ambulanten medizinischen Versorgung (Forschungsbericht des Bundesminister für Arbeit und Sozialordnung, Band 99) Bonn 1984Google Scholar
  3. (3).
    Hartunian NS, Smart CN, Thompson MS (1980) The incidence and economic costs of major health impairments: A comparative analysis. In: American Journal of Public Health, vol. 70, no. 12Google Scholar
  4. (4).
    Henke K-D, Behrens C, Arab L, Schlierf G (1986) Die Kosten emährungsbedingter Krankheiten (Schriftenreihe des Bundesministers für Jugend, Familie und Gesundheit, Band 179 ) Kohlhammer, Stuttgart Berlin Köln MainzGoogle Scholar
  5. (5).
    Hu T-W, Sandifer FH (1981) Synthesis of cost of illness methodology, National Center for Health Services ReserachGoogle Scholar
  6. (6).
    Lawrence L, McLemore T (1983) 1981 Summary: National Ambulatory Medical Care Survey. In: advancedata no. 88, DHHS Pub. No. ( PHS ) 83–1250.Google Scholar
  7. (7).
    Schwartz FW, Schwefel D (eds) (1980) Diagnosen in der ambulanten Versorgung — Eine Expertenumfrage in der Bundesrepublik Deutschland, 2nd edn. Deutscher Ärzte-Verlag, KölnGoogle Scholar
  8. (8).
    Schwartz FW, Kerek-Bodden HE, Schach E, Schach S, Wagner P (1984) EVaS-Study: Purpose of the Study. In: van Eimeren W, Engelbrecht R, Flagle CD (eds) Third International Conference on System Science in Health Care. Springer, Heidelberg Berlin New YorkGoogle Scholar
  9. (9).
    Schwefel D, John J, Potthoff P, van Eimeren W (1987) Diagnosenstruktur in der ambulanten Versorgung. Springer, Berlin Heidelberg New YorkGoogle Scholar
  10. (10).
    Scitovsky AA (1982) Estimating the direct costs of illness. In: Milbank Memorial Fund Quarterly (Health and Society), vol. 60, no. 3: 463–491Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • B. Häussler
  • K. Jacobs

There are no affiliations available

Personalised recommendations